Skip to main content
Fig. 7 | Stem Cell Research & Therapy

Fig. 7

From: A robust reprogramming strategy for generating hepatocyte-like cells usable in pharmaco-toxicological studies

Fig. 7

Characterization of disease phenotype in diHLC-TAATD. iHDF-TAATD were reprogrammed to diHLC- TAATD by incubation in HMM media containing 250 ng/ml DOX for 12 days. A Sequence of retrotranscribed SERPINA1 mRNA isolated from diHLC-TAATD corresponding to the region of exon 6 containing the Glu366Lys mutation (PiZZ genotype). B Representative fluorescence images of cells immunostained with antibodies against polymeric and standard human alpha-1 antitrypsin in diHLC-T and diHLC-TAATD. Nuclei were stained with DAPI. White bar equals 75 μm. C AAT secretion was estimated from 24-h cell media using an ELISA kit. Data correspond to the average of three different clones per genotype plus standard deviation. D mRNA level of four differentially expressed genes based on results previously published [42]. Values depicted correspond to the average of three different diHLC-T clones with WT and PiZZ genotype. All values correspond to average plus standard deviation

Back to article page